Skip to main content
Premium Trial:

Request an Annual Quote

Nanostring Breast Cancer 360 Research Panel

NanoString Technologies has launched the Breast Cancer 360T (BC 360) research panel, which provides a multimodal analysis of tumor gene expression, microenvironment, and immune response. The 770-gene expression panel is the second in a series of 360 panels, following NanoString's PanCancer Immuno-Oncology 360 panel that was launched last year. It includes content across important breast cancer pathways and validated signatures including NanoString's PAM50 signature for breast cancer subtyping and its Tumor Inflammation Signature, as well as other targets involved in DNA damage repair deficiency, inhibitory immune signaling, and immune cell population abundance.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.